Dual Targeting Of mTOR/IL-17A And Autophagy By Fisetin Alleviates Psoriasis-Like Skin Inflammation
| dc.contributor.author | Roy, T. | |
| dc.contributor.author | Banang-Mbeumi, S. | |
| dc.contributor.author | Boateng, S.T. | |
| dc.contributor.author | Ruiz, E.M. | |
| dc.contributor.author | Chamcheu, R.-C.N. | |
| dc.contributor.author | Kang, L. | |
| dc.contributor.author | King, J.A. | |
| dc.contributor.author | Walker, A.L. | |
| dc.contributor.author | Nagalo, B.M. | |
| dc.contributor.author | Kousoulas, K.G. | |
| dc.contributor.author | Esnault, S. | |
| dc.contributor.author | Huang, S. | |
| dc.contributor.author | Chamcheu, J.C. | |
| dc.date.accessioned | 2026-11-02T13:24:13Z | |
| dc.date.issued | 2023-01 | |
| dc.description.abstract | Psoriasis is a chronic autoimmune inflammatory skin disorder characterized by epidermal hyperplasia and aberrant immune response. In addition to aberrant cytokine production, psoriasis is associated with activation of the Akt/mTOR pathway. mTOR/S6K1 regulates T-lymphocyte activation and migration, keratinocytes proliferation and is upregulated in psoriatic lesions. Several drugs that target Th1/Th17 cytokines or their receptors have been approved for treating psoriasis in humans with variable results necessitating improved therapies. Fisetin, a natural dietary polyphenol with anti-oxidant and anti-proliferative properties, covalently binds mTOR/S6K1. The effects of fisetin on psoriasis and its underlying mechanisms have not been clearly defined. Here, we evaluated the immunomodulatory effects of fisetin on Th1/Th17-cytokine-activated adult human epidermal keratinocytes (HEKa) and anti-CD3/CD28-stimulated inflammatory CD4 + T cells and compared these activities with those of rapamycin (an mTOR inhibitor). Transcriptomic analysis of HEKa revealed 12,713 differentially expressed genes (DEGs) in the fisetin-treated group compared to 7,374 DEGs in the rapamycin-treated group, both individually compared to a cytokine treated group. Gene ontology analysis revealed enriched functional groups related to PI3K/Akt/mTOR signaling pathways, psoriasis, and epidermal development. Using in silico molecular modeling, we observed a high binding affinity of fisetin to IL-17A. In vitro, fisetin significantly inhibited mTOR activity, increased the expression of autophagy markers LC3A/B and Atg5 in HEKa cells and suppressed the secretion of IL-17A by activated CD4+ T lymphocytes or T lymphocytes co-cultured with HEKa. Topical administration of fisetin in an imiquimod (IMQ)-induced mouse psoriasis model exhibited a better effect than rapamycin in reducing psoriasis-like inflammation and Akt/mTOR phosphorylation and promoting keratinocyte differentiation and autophagy in mice skin lesions. Fisetin also significantly inhibited T-lymphocytes and F4/80+ macrophage infiltration into skin. We conclude that fisetin potently inhibits IL17A and the Akt/mTOR pathway and promotes keratinocyte differentiation and autophagy to alleviate IMQ-induced psoriasis-like disease in mice. Altogether, our findings suggest fisetin as a potential treatment for psoriasis and possibly other inflammatory skin diseases. | en |
| dc.identifier.uri | https://doi.org/10.3389/fimmu.2022.1075804 | |
| dc.identifier.uri | https://space.uenr.edu.gh/handle/123456789/134 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Frontiers in Immunology, Volume 13, Article 1075804 | |
| dc.subject | autophagy | |
| dc.subject | fisetin | |
| dc.subject | psoriasis | |
| dc.subject | Akt/mTOR and IL-17A | |
| dc.subject | rapamycin | |
| dc.subject | topical administration | |
| dc.subject | psoriasis-like skin inflammation | |
| dc.subject | keratinocytes RNA-sequencing | |
| dc.title | Dual Targeting Of mTOR/IL-17A And Autophagy By Fisetin Alleviates Psoriasis-Like Skin Inflammation | en |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 2023 - Dual targeting of mTOR IL-17A and autophagy by fisetin alleviat.pdf
- Size:
- 11.52 MB
- Format:
- Adobe Portable Document Format
